Divya Srivastava
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Divya Srivastava has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Rajiv I. Nijhawan
7 shared publications- Rajiv I. Nijhawan
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
4 shared publications Andrew Matsumoto
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
3 shared publicationsAgnes Kim
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
1 shared publication- Andrew Matsumoto
Department of Dermatology, University of Texas Southwestern Medical Center
1 shared publication - Cerrene N. Giordano
Henry Ford Hospital
1 shared publication
Latest Publications
- 16 August 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (6) , e185
Response to Bennett et al., “[Correction to excision margins for melanoma in situ on the head and neck]”
- 16 August 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (6) , e185
Response to Bennett et al., “[Correction to excision margins for melanoma in situ on the head and neck]”
- 28 October 2022
- Published by Elsevier in Dermatologic Clinics
- Vol. 41 (1) , 163-174
Approaches to Tumors of the Nail Unit and Genitalia
- 28 October 2022
- Published by Elsevier in Dermatologic Clinics
- Vol. 41 (1) , 163-174
Approaches to Tumors of the Nail Unit and Genitalia
- Open Access
- 7 May 2022
- Published by Elsevier in JAAD International
- Vol. 8, 16-18
Long-term outcomes of high-risk basal cell carcinoma treated with Mohs micrographic surgery
- 7 May 2022
- Published by Elsevier in JAAD International
- Vol. 8, 16-18
Open AccessLong-term outcomes of high-risk basal cell carcinoma treated with Mohs micrographic surgery
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , 588-595
Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , 588-595
Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery
- 8 March 2021
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 314 (7) , 705-707
Basal cell carcinoma histopathologic upgrading and Mohs micrographic surgery: a single institution, retrospective review
Basal cell carcinoma (BCC) histopathology can differ between original biopsy and wide local excision or Mohs micrographic surgery (MMS). We aimed to analyze the rate of difference in BCC subtypes between the original biopsy and MMS frozen section to determine the rate of histopathological upgrading and also to identify risk factors for upgrading. A single institution, retrospective cohort study of patients with BCC treated with MMS was performed at the University of Texas Southwestern. Screening criteria identified 3235 BCCs. Of these, 1289 tumors were identified as having lower-grade pathology on initial biopsy. 291 (22.6%) of the lower-grade pathology tumors were upgraded to a higher-grade pathology. Tumors with an upgraded pathology had significantly greater number of stages performed [mean of 2.5 vs 2.3, p < 0.001], pre-operative size [median of 1.0 cm vs 0.8 cm, p < 0.001], and post-operative size [median of 2.0 cm vs 1.7 cm, p < 0.001]. These tumors were significantly more likely to require more advanced repairs [36.8% (107/291) vs 29.8% (297/998), p = 0.03] and be referred for post-operative radiation [1.7% (5/291) vs 0.0% (0/998), p < 0.001]. In addition, there were a significantly greater number of tumors considered recurrent (received prior surgical or non-surgical treatment) in the upgraded pathology group [8.6% (25/291) vs 3.9% (39/998), p < 0.01]. Our study highlights that a significant proportion of these patients are under-graded on initial biopsy and would benefit from more definitive intervention, such as MMS.
- 8 March 2021
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 314 (7) , 705-707
Basal cell carcinoma histopathologic upgrading and Mohs micrographic surgery: a single institution, retrospective review
Basal cell carcinoma (BCC) histopathology can differ between original biopsy and wide local excision or Mohs micrographic surgery (MMS). We aimed to analyze the rate of difference in BCC subtypes between the original biopsy and MMS frozen section to determine the rate of histopathological upgrading and also to identify risk factors for upgrading. A single institution, retrospective cohort study of patients with BCC treated with MMS was performed at the University of Texas Southwestern. Screening criteria identified 3235 BCCs. Of these, 1289 tumors were identified as having lower-grade pathology on initial biopsy. 291 (22.6%) of the lower-grade pathology tumors were upgraded to a higher-grade pathology. Tumors with an upgraded pathology had significantly greater number of stages performed [mean of 2.5 vs 2.3, p < 0.001], pre-operative size [median of 1.0 cm vs 0.8 cm, p < 0.001], and post-operative size [median of 2.0 cm vs 1.7 cm, p < 0.001]. These tumors were significantly more likely to require more advanced repairs [36.8% (107/291) vs 29.8% (297/998), p = 0.03] and be referred for post-operative radiation [1.7% (5/291) vs 0.0% (0/998), p < 0.001]. In addition, there were a significantly greater number of tumors considered recurrent (received prior surgical or non-surgical treatment) in the upgraded pathology group [8.6% (25/291) vs 3.9% (39/998), p < 0.01]. Our study highlights that a significant proportion of these patients are under-graded on initial biopsy and would benefit from more definitive intervention, such as MMS.
- 1 October 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (10) , 879-881
Vulvar phyllodes tumor presenting as an epidermoid cyst
- 1 October 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (10) , 879-881
Vulvar phyllodes tumor presenting as an epidermoid cyst
- 11 August 2020
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 47 (1) , 98-103
Nail Unit Melanoma In Situ Treated With Mohs Micrographic Surgery
BACKGROUND: Mohs micrographic surgery (MMS) is under used in the treatment of nail unit melanoma in situ (MIS), with limited studies in the literature. OBJECTIVE: Report clinical outcomes for nail unit MIS using MMS with melanoma antigen recognized by T cells-1 (MART-1) immunostaining. METHODS: A retrospective observational study at a single academic institution of patients with a diagnosis of nail unit MIS treated with MMS with MART-1 immunostaining from January 1, 2006, to December 30, 2016. The primary outcome measure was the recurrence rate after MMS. RESULTS: Fourteen patients were identified. With an average follow-up of 6.0 years (71.6 months; range = 5–139 months), 1 patient developed recurrence 6.6 years after undergoing initial MMS, requiring amputation with no further treatment or recurrence thereafter. CONCLUSION: Mohs micrographic surgery for nail unit MIS offers a high cure rate similar to other surgical modalities and can reduce the need for digital amputation. The evolution of the Mohs technique over time, namely, using MART-1 immunostaining, has led to improvement in treatment outcomes. Performing complete nail unit excision with nail plate remaining intact attached to the nail bed may also contribute to improved outcomes. Further refinement in technique and more data are necessary to continue to advance this treatment.
- 11 August 2020
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 47 (1) , 98-103
Nail Unit Melanoma In Situ Treated With Mohs Micrographic Surgery
BACKGROUND: Mohs micrographic surgery (MMS) is under used in the treatment of nail unit melanoma in situ (MIS), with limited studies in the literature. OBJECTIVE: Report clinical outcomes for nail unit MIS using MMS with melanoma antigen recognized by T cells-1 (MART-1) immunostaining. METHODS: A retrospective observational study at a single academic institution of patients with a diagnosis of nail unit MIS treated with MMS with MART-1 immunostaining from January 1, 2006, to December 30, 2016. The primary outcome measure was the recurrence rate after MMS. RESULTS: Fourteen patients were identified. With an average follow-up of 6.0 years (71.6 months; range = 5–139 months), 1 patient developed recurrence 6.6 years after undergoing initial MMS, requiring amputation with no further treatment or recurrence thereafter. CONCLUSION: Mohs micrographic surgery for nail unit MIS offers a high cure rate similar to other surgical modalities and can reduce the need for digital amputation. The evolution of the Mohs technique over time, namely, using MART-1 immunostaining, has led to improvement in treatment outcomes. Performing complete nail unit excision with nail plate remaining intact attached to the nail bed may also contribute to improved outcomes. Further refinement in technique and more data are necessary to continue to advance this treatment.
- 1 July 2019
- Published by Elsevier in Dermatologic Clinics
- Vol. 37 (3) , 307-317
Cutaneous Surgery in Patients Who Are Pregnant or Breastfeeding
- 1 July 2019
- Published by Elsevier in Dermatologic Clinics
- Vol. 37 (3) , 307-317
Cutaneous Surgery in Patients Who Are Pregnant or Breastfeeding
- 19 April 2019
- Published by Elsevier in Dermatologic Clinics
- Vol. 37 (3) , XV
Practical Updates in Cutaneous Oncology and Dermatologic Surgery
- 19 April 2019
- Published by Elsevier in Dermatologic Clinics
- Vol. 37 (3) , XV
Practical Updates in Cutaneous Oncology and Dermatologic Surgery
- 1 March 2016
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 35 (1) , 13-17
Self-acquired patient images: the promises and the pitfalls
Self-acquired patient images, also known as selfies, are increasingly utilized in the practice of dermatology; however, research on their utility is somewhat limited. While the implementation of selfies has yet to be universally accepted, their role in triage appears to be especially useful. The potential for reducing office wait times, expediting referrals, and providing dermatologic services to patients with limited access to care is promising. In addition, as technology advances, the number of smartphone applications related to dermatology that are available to the general public has risen exponentially. With appropriate standardization, regulation, and confidentiality measures, these tools can be feasible adjuncts in clinical practice, dermatologic surgery, and teledermatology. Selfies likely will have a large role in dermatologic practice and delivery in the future.
- 1 March 2016
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 35 (1) , 13-17
Self-acquired patient images: the promises and the pitfalls
Self-acquired patient images, also known as selfies, are increasingly utilized in the practice of dermatology; however, research on their utility is somewhat limited. While the implementation of selfies has yet to be universally accepted, their role in triage appears to be especially useful. The potential for reducing office wait times, expediting referrals, and providing dermatologic services to patients with limited access to care is promising. In addition, as technology advances, the number of smartphone applications related to dermatology that are available to the general public has risen exponentially. With appropriate standardization, regulation, and confidentiality measures, these tools can be feasible adjuncts in clinical practice, dermatologic surgery, and teledermatology. Selfies likely will have a large role in dermatologic practice and delivery in the future.